TABLE 3.

Effect of in utero protein restriction, accelerated postnatal growth, and CoQ₁₀ supplementation on serum and plasma measurements¹

	Control	Recuperated	Control CoQ10	Recuperated CoQ10	Effect of CoQ10
Hepatic CoQ9, pmol/mg protein	494 ± 28	497 ± 24	872.4 ± 79**	1071 ± 266**	0.003
Hepatic CoQ10, pmol/mg protein	80 ± 7	78 ± 6	146 ± 17**	102 ± 11**	0.002
Fasting plasma glucose, mmol/L	5.6 ± 0.2	5.3 ± 0.1	5.4 ± 0.3	5.24 ± 0.2	0.9
Serum cholesterol, mmol/L	4.8 ± 0.5	4.9 ± 0.4	6.1 ± 0.7*	5.9 ± 0.6*	0.04
Serum trigyclerides, mmol/L	3.8 ± 0.05	3.8 ± 0.4	4.2 ± 0.6*	5.7 ± 0.7*	0.02
Hepatic triglyceride content, g	2.0 ± 0.2	2.3 ± 0.2	2.0 ± 0.1	2.0 ± 0.2	0.3

¹Values are means ± SEMs; n = 10/group. Data were analyzed by using 2-factor ANOVA and Duncan’s post hoc testing, where appropriate. The overall effects of maternal diet and interaction between maternal diet and CoQ₁₀ supplementation were not significant for any of the variables reported in the table. *^,**Effect of CoQ₁₀: *P < 0.05, **P < 0.01. CoQ₁₀, coenzyme Q.